Education
About Us
Working with TipRanks
Follow Us
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
:GPCR
RESEARCH TOOLSreports
GPCR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$19.61 - $62.74
Previous CloseN/A
Volume219.80K
Average Volume (3M)800.19K
Market Cap
$1.36B
Enterprise Value$1.60B
Total Cash (Recent Filing)$126.49M
Total Debt (Recent Filing)$168.00K
Price to Earnings (P/E)―
Beta1.40
Next Earnings
May 08, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.32
Shares Outstanding57,342,846
10 Day Avg. Volume834,256
30 Day Avg. Volume800,194
Standard Deviation0.25
R-Squared0.16
Alpha0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)70.22
Price to Cash Flow (P/CF)-17.30
P/FCF Ratio0.00
Enterprise Value/Market Cap1.18
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-1.69K
Enterprise Value/Ebitda-11.32
Forecast
1Y Price Target
$81.71Price Target Upside244.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
---
Structure Therapeutics, Inc. Sponsored ADR News
---
Bulls Say, Bears Say
Bulls Say
Financial StabilityThe company has more than 2.5 years of cash left, which indicates financial stability.
Market PositionAleniglipron could position itself as a significant competitor on both tolerability and efficacy.
Bears Say
Financial PerformanceStructure reported a net loss of $36.5 million, which was slightly better than estimates but still indicates financial losses.
---
Ownership Overview
10.34% Insiders
39.22% Mutual Funds
<0.01% Other Institutional Investors
49.39% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GPCR FAQ
What was Structure Therapeutics, Inc. Sponsored ADR’s price range in the past 12 months?
Structure Therapeutics, Inc. Sponsored ADR lowest stock price was $19.61 and its highest was $62.74 in the past 12 months.
What is Structure Therapeutics, Inc. Sponsored ADR’s market cap?
Structure Therapeutics, Inc. Sponsored ADR’s market cap is $1.36B.
When is Structure Therapeutics, Inc. Sponsored ADR’s upcoming earnings report date?
Structure Therapeutics, Inc. Sponsored ADR’s upcoming earnings report date is May 08, 2025 which is in 65 days.
How were Structure Therapeutics, Inc. Sponsored ADR’s earnings last quarter?
Structure Therapeutics, Inc. Sponsored ADR released its earnings results on Feb 27, 2025. The company reported -$0.215 earnings per share for the quarter, missing the consensus estimate of -$0.214 by -$0.001.
Is Structure Therapeutics, Inc. Sponsored ADR overvalued?
According to Wall Street analysts Structure Therapeutics, Inc. Sponsored ADR’s price is currently Undervalued.
Does Structure Therapeutics, Inc. Sponsored ADR pay dividends?
Structure Therapeutics, Inc. Sponsored ADR does not currently pay dividends.
What is Structure Therapeutics, Inc. Sponsored ADR’s EPS estimate?
Structure Therapeutics, Inc. Sponsored ADR’s EPS estimate is -0.24.
How many shares outstanding does Structure Therapeutics, Inc. Sponsored ADR have?
Structure Therapeutics, Inc. Sponsored ADR has 57,342,846 shares outstanding.
What happened to Structure Therapeutics, Inc. Sponsored ADR’s price movement after its last earnings report?
Structure Therapeutics, Inc. Sponsored ADR reported an EPS of -$0.215 in its last earnings report, missing expectations of -$0.214. Following the earnings report the stock price went up 4.075%.
Which hedge fund is a major shareholder of Structure Therapeutics, Inc. Sponsored ADR?
Currently, no hedge funds are holding shares in GPCR
---
Structure Therapeutics, Inc. Sponsored ADR Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$81.71 (244.04% Upside)
$81.71 (244.04% Upside)
Blogger Sentiment
Bullish
GPCR Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 7.4%
Last 30 Days ▼ 7.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.11%
12-Months-Change
Fundamentals
Return on Equity
-18.61%
Trailing 12-Months
Asset Growth
87.41%
Trailing 12-Months
Company Description
Structure Therapeutics, Inc. Sponsored ADR
Structure Therapeutics Inc is a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical need.
---
GPCR Stock 12 Month Forecast
Average Price Target
$81.71
▲(244.04% Upside)
Technical Analysis
Best Analysts Covering GPCR
1 Year
1 Year Success Rate
5/14 ratings generated profit
1 Year Average Return
+0.02%
reiterated a buy rating 3 months ago
Copying David Risinger's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of +0.02% per trade.
---